{"id":"https://openalex.org/W2043761487","doi":"https://doi.org/10.1074/jbc.m008867200","title":"Cell Cycle and Biochemical Effects of PD 0183812","display_name":"Cell Cycle and Biochemical Effects of PD 0183812","alternate_titles":[],"publication_year":2001,"publication_date":"2001-05-01","ids":{"openalex":"https://openalex.org/W2043761487","doi":"https://doi.org/10.1074/jbc.m008867200","mag":"2043761487","pmid":"https://pubmed.ncbi.nlm.nih.gov/11278443"},"language":"en","primary_location":{"id":"doi:10.1074/jbc.m008867200","doi":"https://doi.org/10.1074/jbc.m008867200","is_oa":true,"landing_page_url":"https://doi.org/10.1074/jbc.m008867200","pdf_url":null,"source":{"id":"https://openalex.org/S140251998","display_name":"Journal of Biological Chemistry","issn_l":"0021-9258","issn":["0021-9258","1067-8816","1083-351X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biological Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2043761487"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1074/jbc.m008867200","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033059231","display_name":"David W. Fry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David W. Fry","raw_affiliation_strings":["Department of Cancer Research, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, USA","Departments of Cancer Research and Chemistry, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, the"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Research, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Cancer Research and Chemistry, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, the","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000037671","display_name":"David C. Bedford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David C. Bedford","raw_affiliation_strings":["CRC Centre for Cancer Therapeutics at the Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Centre for Cancer Therapeutics at the Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002010328","display_name":"Patricia H. Harvey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patricia H. Harvey","raw_affiliation_strings":["Departments of Cancer Research and Chemistry, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, the"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cancer Research and Chemistry, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, the","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035126806","display_name":"Alexandra Fritsch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139583","display_name":"Cytokinetics (United States)","ror":"https://ror.org/03tx9ss94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210139583"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexandra Fritsch","raw_affiliation_strings":["Cytokinetics, South San Francisco, California 94080, and","Onyx Pharmaceuticals, Richmond, California 94806"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytokinetics, South San Francisco, California 94080, and","institution_ids":["https://openalex.org/I4210139583"]},{"raw_affiliation_string":"Onyx Pharmaceuticals, Richmond, California 94806","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111552156","display_name":"Paul R. Keller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul R. Keller","raw_affiliation_strings":["Departments of Cancer Research and Chemistry, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, the"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cancer Research and Chemistry, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, the","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110006737","display_name":"Zhipei Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Zhipei Wu","raw_affiliation_strings":["Departments of Cancer Research and Chemistry, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, the"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cancer Research and Chemistry, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, the","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070449065","display_name":"Ellen M. Dobrusin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ellen Dobrusin","raw_affiliation_strings":["Departments of Cancer Research and Chemistry, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, the"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cancer Research and Chemistry, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, the","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110908562","display_name":"Wilbur R. Leopold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wilbur R. Leopold","raw_affiliation_strings":["Departments of Cancer Research and Chemistry, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, the"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cancer Research and Chemistry, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, the","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024930357","display_name":"Ali Fattaey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ali Fattaey","raw_affiliation_strings":["Onyx Pharmaceuticals, Richmond, California 94806"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Onyx Pharmaceuticals, Richmond, California 94806","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015193618","display_name":"Michelle Dawn Garrett","orcid":"https://orcid.org/0000-0002-3939-1673","observed_orcids":["https://orcid.org/0000-0002-3939-1673"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michelle D. Garrett","raw_affiliation_strings":["CRC Centre for Cancer Therapeutics at the Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, United Kingdom","Onyx Pharmaceuticals, Richmond, California 94806"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRC Centre for Cancer Therapeutics at the Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, United Kingdom","institution_ids":["https://openalex.org/I142947616"]},{"raw_affiliation_string":"Onyx Pharmaceuticals, Richmond, California 94806","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5015193618"],"corresponding_institution_ids":["https://openalex.org/I142947616"],"apc_list":{"value":3430,"currency":"USD","value_usd":3430},"apc_paid":{"value":3430,"currency":"USD","value_usd":3430},"fwci":7.5834,"has_fulltext":false,"cited_by_count":127,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97815406,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"276","issue":"20","first_page":"16617","last_page":"16623"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.015599999576807022,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk4-inhibitors","display_name":"CDK4 inhibitors","score":0.7429999709129333},{"id":"https://openalex.org/keywords/cdk6-inhibitors","display_name":"CDK6 inhibitors","score":0.9860000014305115},{"id":"https://openalex.org/keywords/rb-phosphorylation","display_name":"retinoblastoma protein phosphorylation","score":0.9160000085830688},{"id":"https://openalex.org/keywords/g1-cell-cycle-arrest","display_name":"G1 cell cycle arrest","score":0.953000009059906},{"id":"https://openalex.org/keywords/p16ink4a","display_name":"p16INK4a","score":0.9380000233650208},{"id":"https://openalex.org/keywords/anticancer-drug-discovery","display_name":"anticancer drug discovery","score":0.5899999737739563},{"id":"https://openalex.org/keywords/cell-proliferation-inhibition","display_name":"cell proliferation inhibition","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.8804888725280762},{"id":"https://openalex.org/C199649820","wikidata":"https://www.wikidata.org/wiki/Q14911762","display_name":"Cyclin-dependent kinase 6","level":5,"score":0.8670338988304138},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.7189914584159851},{"id":"https://openalex.org/C2776062698","wikidata":"https://www.wikidata.org/wiki/Q21111463","display_name":"Retinoblastoma protein","level":4,"score":0.6897715330123901},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5793383121490479},{"id":"https://openalex.org/C11882975","wikidata":"https://www.wikidata.org/wiki/Q24781041","display_name":"Cyclin D","level":5,"score":0.5379119515419006},{"id":"https://openalex.org/C152857842","wikidata":"https://www.wikidata.org/wiki/Q7316321","display_name":"Restriction point","level":5,"score":0.5297756195068359},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5139005184173584},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4669422209262848},{"id":"https://openalex.org/C2778298596","wikidata":"https://www.wikidata.org/wiki/Q17143494","display_name":"CDK inhibitor","level":5,"score":0.4627091884613037},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.42681729793548584},{"id":"https://openalex.org/C51853150","wikidata":"https://www.wikidata.org/wiki/Q14911754","display_name":"Cyclin-dependent kinase 4","level":5,"score":0.4264587461948395},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.4193544089794159},{"id":"https://openalex.org/C16438837","wikidata":"https://www.wikidata.org/wiki/Q5198260","display_name":"Cyclin A","level":5,"score":0.4157330095767975},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27627941966056824},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.19561192393302917}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004261","descriptor_name":"DNA Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004273","descriptor_name":"DNA, Neoplasm","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016160","descriptor_name":"Retinoblastoma Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016193","descriptor_name":"G1 Phase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016213","descriptor_name":"Cyclins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018411","descriptor_name":"Spodoptera","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018844","descriptor_name":"Cyclin-Dependent Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051358","descriptor_name":"Cyclin-Dependent Kinase 4","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051361","descriptor_name":"Cyclin-Dependent Kinase 6","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056741","descriptor_name":"Cyclin D","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1074/jbc.m008867200","doi":"https://doi.org/10.1074/jbc.m008867200","is_oa":true,"landing_page_url":"https://doi.org/10.1074/jbc.m008867200","pdf_url":null,"source":{"id":"https://openalex.org/S140251998","display_name":"Journal of Biological Chemistry","issn_l":"0021-9258","issn":["0021-9258","1067-8816","1083-351X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biological Chemistry","raw_type":"journal-article"},{"id":"pmid:11278443","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11278443","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of biological chemistry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1074/jbc.m008867200","doi":"https://doi.org/10.1074/jbc.m008867200","is_oa":true,"landing_page_url":"https://doi.org/10.1074/jbc.m008867200","pdf_url":null,"source":{"id":"https://openalex.org/S140251998","display_name":"Journal of Biological Chemistry","issn_l":"0021-9258","issn":["0021-9258","1067-8816","1083-351X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biological Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W31572314","https://openalex.org/W143753117","https://openalex.org/W273460782","https://openalex.org/W1501492534","https://openalex.org/W1557240175","https://openalex.org/W1569698611","https://openalex.org/W1599861993","https://openalex.org/W1610470214","https://openalex.org/W1845790496","https://openalex.org/W1851389060","https://openalex.org/W1871919982","https://openalex.org/W1911118961","https://openalex.org/W1919908042","https://openalex.org/W1968847718","https://openalex.org/W1974478882","https://openalex.org/W1981652313","https://openalex.org/W1985075123","https://openalex.org/W1991595805","https://openalex.org/W1992772703","https://openalex.org/W2004294575","https://openalex.org/W2007305884","https://openalex.org/W2010493387","https://openalex.org/W2014613601","https://openalex.org/W2029667363","https://openalex.org/W2058184498","https://openalex.org/W2061159855","https://openalex.org/W2072791559","https://openalex.org/W2077230415","https://openalex.org/W2087798525","https://openalex.org/W2090377897","https://openalex.org/W2093188317","https://openalex.org/W2095690095","https://openalex.org/W2098517912","https://openalex.org/W2108958930","https://openalex.org/W2112555367","https://openalex.org/W2113901486","https://openalex.org/W2120607327","https://openalex.org/W2128635872","https://openalex.org/W2138103542","https://openalex.org/W2166944576","https://openalex.org/W2169344668","https://openalex.org/W2169927110","https://openalex.org/W2333464935","https://openalex.org/W2394626707","https://openalex.org/W2883903927"],"related_works":["https://openalex.org/W2072791559","https://openalex.org/W2091851204","https://openalex.org/W3144954426","https://openalex.org/W2040564571","https://openalex.org/W2133115100","https://openalex.org/W2154626333","https://openalex.org/W1851389060","https://openalex.org/W2096979580","https://openalex.org/W2219817965"],"abstract_inverted_index":{"Progression":[0],"through":[1],"the":[2,6,12,18,32,38,45,56,82,92,122,179,194],"G1":[3,132],"phase":[4],"of":[5,11,37,44,60,75,86,94,104,121,144,152,169,173,181,193],"cell":[7,123,187],"cycle":[8,188],"requires":[9],"phosphorylation":[10,154],"retinoblastoma":[13],"gene":[14],"product":[15],"(pRb)":[16],"by":[17,31],"cyclin":[19,61],"D-dependent":[20,62],"kinases":[21],"CDK4":[22,106],"and":[23,52,100,107,147,155],"CDK6,":[24],"whose":[25],"activity":[26,64],"can":[27],"specifically":[28],"be":[29],"blocked":[30],"CDK":[33],"inhibitor":[34,103],"p16(INK4A).":[35],"Misregulation":[36],"pRb/cyclin":[39,195],"D/p16(INK4A)":[40,196],"pathway":[41],"is":[42,112],"one":[43],"most":[46],"common":[47],"events":[48],"in":[49,91,142,158,178,190],"human":[50],"cancer":[51],"has":[53],"lead":[54],"to":[55],"suggestion":[57],"that":[58,120],"inhibition":[59],"kinase":[63,109],"may":[65],"have":[66],"therapeutic":[67,176],"value":[68],"as":[69,84,97,175],"an":[70],"anticancer":[71],"treatment.":[72],"Through":[73],"screening":[74],"a":[76,98,131,150,156,166],"chemical":[77,171],"library,":[78],"we":[79],"initially":[80],"identified":[81],"[2,3-d]pyridopyrimidines":[83],"inhibitors":[85],"CDK4.":[87],"Chemical":[88],"modification":[89],"resulted":[90],"identification":[93],"PD":[95,137],"0183812":[96],"potent":[99],"highly":[101],"selective":[102],"both":[105],"CDK6":[108],"activity,":[110],"which":[111,160],"competitive":[113],"with":[114,136,149,183],"ATP.":[115],"Flow":[116],"cytometry":[117],"experiments":[118],"showed":[119],"lines":[124],"tested,":[125],"only":[126],"those":[127],"expressing":[128],"pRb":[129,153],"demonstrated":[130],"arrest":[133,140],"when":[134],"treated":[135],"0183812.":[138],"This":[139],"correlated":[141],"terms":[143],"incubation":[145],"time":[146],"potency":[148],"loss":[151],"block":[157],"proliferation,":[159],"was":[161],"reversible.":[162],"These":[163],"results":[164],"suggest":[165],"potential":[167],"use":[168],"this":[170],"class":[172],"compounds":[174],"agents":[177],"treatment":[180],"tumors":[182],"functional":[184],"pRb,":[185],"possessing":[186],"aberrations":[189],"other":[191],"members":[192],"pathway.":[197]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2043761487","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
